DM199 (rinvecalinase alfa) — Interim data
Q1 2027
As we approach enrollment of the 200 th participant, we estimate that the interim analysis will be completed in the first quarter of 2027.Source filing
DMAC biotech catalysts & pipeline
DIAMEDICA THERAPEUTICS INC · Data as of 2026-10-25